Contribution of remote monitoring to the early diagnosis of implantable cardioverter-defibrillator shocks in the patient with cardiac resynchronisation therapy

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F13%3A00060799" target="_blank" >RIV/00159816:_____/13:00060799 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.1016/j.crvasa.2012.12.003" target="_blank" >http://dx.doi.org/10.1016/j.crvasa.2012.12.003</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.crvasa.2012.12.003" target="_blank" >10.1016/j.crvasa.2012.12.003</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Contribution of remote monitoring to the early diagnosis of implantable cardioverter-defibrillator shocks in the patient with cardiac resynchronisation therapy

Popis výsledku v původním jazyce

We present the case of a 68-year-old man with coronary artery disease and a history of recurrent myocardial infarctions, having left ventricular ejection fraction 25% in NYHA functional class III. The patient received a biventricular cardioverter-defibrillator (ICD) Biotronik Lumax 340 HF-T in November 2008 from the primary prophylactic indication. Remote monitoring using the Biotronik Home MonitoringTM (HM) system was activated since device implantation. Up to April 2012 the patient received five shocks including 3 appropriate VF therapies and 2 inappropriate ICD shocks (due to T-wave oversensing and atrial flutter degenerating to VF after ATPs). All arrhythmic events were promptly detected by the HM system with a rapid consequent pharmacological andnon-pharmacological intervention (radiofrequency catheter ablation of atrial arrhythmia and reprogramming the device). This case points out that prophylactic ICD implantation is a justifiable method for the prevention of arrhythmic death

Název v anglickém jazyce

Contribution of remote monitoring to the early diagnosis of implantable cardioverter-defibrillator shocks in the patient with cardiac resynchronisation therapy

Popis výsledku anglicky

We present the case of a 68-year-old man with coronary artery disease and a history of recurrent myocardial infarctions, having left ventricular ejection fraction 25% in NYHA functional class III. The patient received a biventricular cardioverter-defibrillator (ICD) Biotronik Lumax 340 HF-T in November 2008 from the primary prophylactic indication. Remote monitoring using the Biotronik Home MonitoringTM (HM) system was activated since device implantation. Up to April 2012 the patient received five shocks including 3 appropriate VF therapies and 2 inappropriate ICD shocks (due to T-wave oversensing and atrial flutter degenerating to VF after ATPs). All arrhythmic events were promptly detected by the HM system with a rapid consequent pharmacological andnon-pharmacological intervention (radiofrequency catheter ablation of atrial arrhythmia and reprogramming the device). This case points out that prophylactic ICD implantation is a justifiable method for the prevention of arrhythmic death

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FA - Kardiovaskulární nemoci včetně kardiochirurgie

OECD FORD obor

—

Projekt

<a href="/cs/project/ED1.100%2F02%2F0123" target="_blank" >ED1.100/02/0123: Fakultní nemocnice u sv. Anny v Brně - Mezinárodní centrum klinického výzkumu (FNUSA - ICRC)</a><br>

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2013

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Cor et Vasa

ISSN

0010-8650

e-ISSN

—

Svazek periodika

55

Číslo periodika v rámci svazku

3

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

4

Strana od-do

"E281"-"E284"

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—